COVID-19: Changing how we think about finance for global health

by Michael Anderson, Chief Executive Officer When future generations chart the COVID-19 pandemic, they will note that ‘business as usual’ was set aside to protect lives. Unprecedented collaboration between science, industry and government is driving new vaccine development at record speed. Chinese scientists shared the virus genome within days. Anti-viral treatments are being tested in…

Leveraging at scale to tackle chronic illness

by Michelle Akande, Vice President, Health Markets Significant progress has been made against infectious diseases over the past two decades. In 2004, an estimated 1.7 million people died of AIDS-related illness but by 2018, that figured had dropped to 770,000. Equally impressive strides have been made in the fight against malaria, with deaths decreasing by…

Hema Srinivasan appointed Chief Access Officer

February 24, 2020 – MedAccess is pleased to announce the appointment of Hema Srinivasan as the social finance company’s new Chief Access Officer. Hema brings over a decade of experience in healthcare, market shaping and access programmes to reach people with life-saving medicines, medical devices and diagnostics. Hema will join MedAccess at the end of…